IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,300 | -93.3% | 35,011 | -90.5% | 0.00% | -100.0% |
| Q4 2022 | $2,360,868 | +178.4% | 369,463 | +625.1% | 0.01% | +150.0% |
| Q1 2022 | $848,000 | -94.8% | 50,953 | -94.1% | 0.00% | -93.3% |
| Q4 2021 | $16,440,000 | +3435.5% | 861,160 | +4719.8% | 0.03% | +1400.0% |
| Q2 2021 | $465,000 | -64.9% | 17,867 | -57.3% | 0.00% | -66.7% |
| Q1 2021 | $1,323,000 | -30.7% | 41,799 | -28.0% | 0.01% | -50.0% |
| Q3 2020 | $1,910,000 | +154.0% | 58,026 | +111.8% | 0.01% | +140.0% |
| Q2 2020 | $752,000 | +1292.6% | 27,391 | +1305.4% | 0.01% | – |
| Q4 2019 | $54,000 | -99.5% | 1,949 | -99.8% | 0.00% | -100.0% |
| Q1 2019 | $10,766,000 | +150.6% | 1,132,032 | +133.2% | 0.05% | +15.9% |
| Q4 2018 | $4,296,000 | +776.7% | 485,506 | +1574.7% | 0.04% | +120.0% |
| Q1 2018 | $490,000 | – | 28,991 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |